Abstract
Objective To examine changing trends of uncertainty stress, and its impact on disease fear and prevention behaviors during the Chinese COVID-19 epidemic using a prospective observational study.
Methods The study employed a longitudinal design. Participants were recruited for an online panel survey from chat groups on social media platforms. There were 5 waves of interviews. Information on uncertainty stress and related variables were collected via the online survey. Descriptive statistics and the GIM program were used for data analysis.
Results Participants numbered 150 for the linkable baseline survey and 102 (68%) for the final survey. Uncertainty stress(β: -0.047, S.E: 0.118, p>0.05) did not show a statistically significant temporal change trend over the observation period. Disease fear manifested a statistically significant downwards trend (β: -0.342, S.E: 0.157, p<0.05), and prevention behaviors indicated an upwards trend (β: 0.048, S.E: 0.021, p<0.05) during the observation period. Uncertainty stress was positively associated with disease fear (β: 0.45046, S.E: 0.05964, p<0.0001), and negatively associated with self-efficacy (β: -0.6698, S.E: 0.01035, p<0.0001), and prevention behaviors (β:-0.02029, S.E: 0.00876, p: 0.0209).
Conclusion This study yielded new information about uncertainty stress among Chinese people during the COVID-19 epidemic. Policy changes and public education are essential for minimizing the negative effects of uncertainty stress in disease prevention.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is partly supported by the National Nature Science Foundation of China (Major Project 71490733)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approved by the Ethics Review Committee of Zhejiang University
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data sharing not applicable to this article because the datasets we used belongs to our Centre for Tobacco Control Research Zhejiang University School of Medicine. Please contact corresponding author for data requests.
